Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000147233 | SCV000194602 | pathogenic | Microcephalic osteodysplastic primordial dwarfism type II | 2013-09-09 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000147233 | SCV002785287 | pathogenic | Microcephalic osteodysplastic primordial dwarfism type II | 2022-02-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003556191 | SCV004298829 | pathogenic | not provided | 2023-12-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg2973*) in the PCNT gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PCNT are known to be pathogenic (PMID: 18174396, 22821869). This variant is present in population databases (rs587784321, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with PCNT-related conditions (PMID: 21270239). ClinVar contains an entry for this variant (Variation ID: 159681). For these reasons, this variant has been classified as Pathogenic. |